Item no.
CIL-EO-5279
Unit
5 x 0,2 mL
Shipment details
De Minimis UN1920 3 III E1
Back to your search result
Description
Chemical purity: 98%
Hazards
Structure formula
Contents
| Analyte | CAS Number | Concentration | Unit | Additional information | Method |
|---|---|---|---|---|---|
2,4,4'-Tribromodiphenyl Ether
|
[41318-75-6] | 1 | ng/mL | CS1, BDE 28 | |
2,2',4,4'-Tetrabromodiphenyl Ether
|
[5436-43-1] | 1 | ng/mL | CS1, BDE 47 | |
2,2',4,4',5-Pentabromodiphenyl Ether
|
[60348-60-9] | 1 | ng/mL | CS1, BDE 99 | |
2,2',4,4',6-Pentabromodiphenyl Ether
|
[189084-64-8] | 1 | ng/mL | CS1, BDE 100 | |
2,2',4,4',5,5'-Hexabromodiphenyl Ether
|
[68631-49-2] | 1 | ng/mL | CS1, BDE 153 | |
2,2',4,4',5,6'-Hexabromodiphenyl Ether
|
[207122-15-4] | 1 | ng/mL | CS1, BDE 154 | |
2,2',3,4,4',5',6-Heptabromodiphenyl Ether
|
[207122-16-5] | 1 | ng/mL | CS1, BDE 183 | |
Decabromodiphenyl ether (BDE 209)
|
[1163-19-5] | 10 | ng/mL | CS1, BDE 209 | |
2,4,4'-Tribromodiphenyl ether (13C12,99%) (BDE 28)
|
[41318-75-6]/unlabelled | 100 | ng/mL | CS1, BDE 28L | |
2,2',4,4'-Tetrabromodiphenyl ether (13C12,99%) (BDE 47)
|
[5436-43-1]/unlabelled | 100 | ng/mL | CS1, BDE 47L | |
2,2',4,4',5-Pentabromodiphenyl ether (13C12,99%) (BDE 99)
|
[60348-60-9]/unlabelled | 100 | ng/mL | CS1, BDE 99L | |
2,2',4,4',6-Pentabromodiphenyl ether (13C12,99%) (BDE 100)
|
[189084-64-8]/unlabelled | 100 | ng/mL | CS1, BDE 100L | |
2,2',4,4',5,5'-Hexabromodiphenyl ether (13C12,99%) (BDE 153)
|
[68631-49-2]/unlabelled | 100 | ng/mL | CS1, BDE 153L | |
2,2',4,4',5,6'-Hexabromodiphenyl ether (13C12,99%) (BDE 154)
|
[488710-23-2] | 100 | ng/mL | CS1, BDE 154L | |
2,2',3,4,4',5',6-Heptabromodiphenyl ether (13C12,99%) (BDE 183)
|
[207122-16-5]/unlabelled | 100 | ng/mL | CS1, BDE 183L | |
Decabromodiphenyl ether (13C12,99%) (BDE 209)
|
[1163-19-5]/unlabelled | 1000 | ng/mL | CS1, BDE 209L | |
2,2',3,4,4',6-Hexabromodiphenyl ether (13C12,99%) (BDE 139)
|
[446254-96-2]/unlabelled | 100 | ng/mL | CS1, Labeled Clean-up, BDE 139L | |
2,2',5,5'-Tetrachlorobiphenyl (13C12,99%) (IUPAC #52)
|
[208263-80-3] | 100 | ng/mL | CS1, Labeled Injection Internal, PCB-52L | |
2,2',3,4,4',5'-Hexachlorobiphenyl (13C12,99%) (IUPAC #138)
|
[208263-66-5] | 100 | ng/mL | CS1, Labeled Injection Internal, PCB-138L | |
2,4,4'-Tribromodiphenyl Ether
|
[41318-75-6] | 5 | ng/mL | CS2, BDE 28 | |
2,2',4,4'-Tetrabromodiphenyl Ether
|
[5436-43-1] | 5 | ng/mL | CS2, BDE 47 | |
2,2',4,4',5-Pentabromodiphenyl Ether
|
[60348-60-9] | 5 | ng/mL | CS2, BDE 99 | |
2,2',4,4',6-Pentabromodiphenyl Ether
|
[189084-64-8] | 5 | ng/mL | CS2, BDE 100 | |
2,2',4,4',5,5'-Hexabromodiphenyl Ether
|
[68631-49-2] | 5 | ng/mL | CS2, BDE 153 | |
2,2',4,4',5,6'-Hexabromodiphenyl Ether
|
[207122-15-4] | 5 | ng/mL | CS2, BDE 154 | |
2,2',3,4,4',5',6-Heptabromodiphenyl Ether
|
[207122-16-5] | 5 | ng/mL | CS2, BDE 183 | |
Decabromodiphenyl ether (BDE 209)
|
[1163-19-5] | 50 | ng/mL | CS2, BDE 209 | |
2,4,4'-Tribromodiphenyl ether (13C12,99%) (BDE 28)
|
[41318-75-6]/unlabelled | 100 | ng/mL | CS2, BDE 28L | |
2,2',4,4'-Tetrabromodiphenyl ether (13C12,99%) (BDE 47)
|
[5436-43-1]/unlabelled | 100 | ng/mL | CS2, BDE 47L | |
2,2',4,4',5-Pentabromodiphenyl ether (13C12,99%) (BDE 99)
|
[60348-60-9]/unlabelled | 100 | ng/mL | CS2, BDE 99L | |
2,2',4,4',6-Pentabromodiphenyl ether (13C12,99%) (BDE 100)
|
[189084-64-8]/unlabelled | 100 | ng/mL | CS2, BDE 100L | |
2,2',4,4',5,5'-Hexabromodiphenyl ether (13C12,99%) (BDE 153)
|
[68631-49-2]/unlabelled | 100 | ng/mL | CS2, BDE 153L | |
2,2',4,4',5,6'-Hexabromodiphenyl ether (13C12,99%) (BDE 154)
|
[488710-23-2] | 100 | ng/mL | CS2, BDE 154L | |
2,2',3,4,4',5',6-Heptabromodiphenyl ether (13C12,99%) (BDE 183)
|
[207122-16-5]/unlabelled | 100 | ng/mL | CS2, BDE 183L | |
Decabromodiphenyl ether (13C12,99%) (BDE 209)
|
[1163-19-5]/unlabelled | 1000 | ng/mL | CS2, BDE 209L | |
2,2',3,4,4',6-Hexabromodiphenyl ether (13C12,99%) (BDE 139)
|
[446254-96-2]/unlabelled | 100 | ng/mL | CS2, Labeled Clean-up, BDE 139L | |
2,2',5,5'-Tetrachlorobiphenyl (13C12,99%) (IUPAC #52)
|
[208263-80-3] | 100 | ng/mL | CS2, Labeled Injection Internal, PCB-52L | |
2,2',3,4,4',5'-Hexachlorobiphenyl (13C12,99%) (IUPAC #138)
|
[208263-66-5] | 100 | ng/mL | CS2, Labeled Injection Internal, PCB-138L | |
2,4,4'-Tribromodiphenyl Ether
|
[41318-75-6] | 50 | ng/mL | CS3, BDE 28 | |
2,2',4,4'-Tetrabromodiphenyl Ether
|
[5436-43-1] | 50 | ng/mL | CS3, BDE 47 | |
2,2',4,4',5-Pentabromodiphenyl Ether
|
[60348-60-9] | 50 | ng/mL | CS3, BDE 99 | |
2,2',4,4',6-Pentabromodiphenyl Ether
|
[189084-64-8] | 50 | ng/mL | CS3, BDE 100 | |
2,2',4,4',5,5'-Hexabromodiphenyl Ether
|
[68631-49-2] | 50 | ng/mL | CS3, BDE 153 | |
2,2',4,4',5,6'-Hexabromodiphenyl Ether
|
[207122-15-4] | 50 | ng/mL | CS3, BDE 154 | |
2,2',3,4,4',5',6-Heptabromodiphenyl Ether
|
[207122-16-5] | 50 | ng/mL | CS3, BDE 183 | |
Decabromodiphenyl ether (BDE 209)
|
[1163-19-5] | 500 | ng/mL | CS3, BDE 209 | |
2,4,4'-Tribromodiphenyl ether (13C12,99%) (BDE 28)
|
[41318-75-6]/unlabelled | 100 | ng/mL | CS3, BDE 28L | |
2,2',4,4'-Tetrabromodiphenyl ether (13C12,99%) (BDE 47)
|
[5436-43-1]/unlabelled | 100 | ng/mL | CS3, BDE 47L | |
2,2',4,4',5-Pentabromodiphenyl ether (13C12,99%) (BDE 99)
|
[60348-60-9]/unlabelled | 100 | ng/mL | CS3, BDE 99L | |
2,2',4,4',6-Pentabromodiphenyl ether (13C12,99%) (BDE 100)
|
[189084-64-8]/unlabelled | 100 | ng/mL | CS3, BDE 100L | |
2,2',4,4',5,5'-Hexabromodiphenyl ether (13C12,99%) (BDE 153)
|
[68631-49-2]/unlabelled | 100 | ng/mL | CS3, BDE 153L | |
2,2',4,4',5,6'-Hexabromodiphenyl ether (13C12,99%) (BDE 154)
|
[488710-23-2] | 100 | ng/mL | CS3, BDE 154L | |
2,2',3,4,4',5',6-Heptabromodiphenyl ether (13C12,99%) (BDE 183)
|
[207122-16-5]/unlabelled | 100 | ng/mL | CS3, BDE 183L | |
Decabromodiphenyl ether (13C12,99%) (BDE 209)
|
[1163-19-5]/unlabelled | 1000 | ng/mL | CS3, BDE 209L | |
2,2',3,4,4',6-Hexabromodiphenyl ether (13C12,99%) (BDE 139)
|
[446254-96-2]/unlabelled | 100 | ng/mL | CS3, Labeled Clean-up, BDE 139L | |
2,2',5,5'-Tetrachlorobiphenyl (13C12,99%) (IUPAC #52)
|
[208263-80-3] | 100 | ng/mL | CS3, Labeled Injection Internal, PCB-52L | |
2,2',3,4,4',5'-Hexachlorobiphenyl (13C12,99%) (IUPAC #138)
|
[208263-66-5] | 100 | ng/mL | CS3, Labeled Injection Internal, PCB-138L | |
2,4,4'-Tribromodiphenyl Ether
|
[41318-75-6] | 500 | ng/mL | CS4, BDE 28 | |
2,2',4,4'-Tetrabromodiphenyl Ether
|
[5436-43-1] | 500 | ng/mL | CS4, BDE 47 | |
2,2',4,4',5-Pentabromodiphenyl Ether
|
[60348-60-9] | 500 | ng/mL | CS4, BDE 99 | |
2,2',4,4',6-Pentabromodiphenyl Ether
|
[189084-64-8] | 500 | ng/mL | CS4, BDE 100 | |
2,2',4,4',5,5'-Hexabromodiphenyl Ether
|
[68631-49-2] | 500 | ng/mL | CS4, BDE 153 | |
2,2',4,4',5,6'-Hexabromodiphenyl Ether
|
[207122-15-4] | 500 | ng/mL | CS4, BDE 154 | |
2,2',3,4,4',5',6-Heptabromodiphenyl Ether
|
[207122-16-5] | 500 | ng/mL | CS4, BDE 183 | |
Decabromodiphenyl ether (BDE 209)
|
[1163-19-5] | 5000 | ng/mL | CS4, BDE 209 | |
2,4,4'-Tribromodiphenyl ether (13C12,99%) (BDE 28)
|
[41318-75-6]/unlabelled | 100 | ng/mL | CS4, BDE 28L | |
2,2',4,4'-Tetrabromodiphenyl ether (13C12,99%) (BDE 47)
|
[5436-43-1]/unlabelled | 100 | ng/mL | CS4, BDE 47L | |
2,2',4,4',5-Pentabromodiphenyl ether (13C12,99%) (BDE 99)
|
[60348-60-9]/unlabelled | 100 | ng/mL | CS4, BDE 99L | |
2,2',4,4',6-Pentabromodiphenyl ether (13C12,99%) (BDE 100)
|
[189084-64-8]/unlabelled | 100 | ng/mL | CS4, BDE 100L | |
2,2',4,4',5,5'-Hexabromodiphenyl ether (13C12,99%) (BDE 153)
|
[68631-49-2]/unlabelled | 100 | ng/mL | CS4, BDE 153L | |
2,2',4,4',5,6'-Hexabromodiphenyl ether (13C12,99%) (BDE 154)
|
[488710-23-2] | 100 | ng/mL | CS4, BDE 154L | |
2,2',3,4,4',5',6-Heptabromodiphenyl ether (13C12,99%) (BDE 183)
|
[207122-16-5]/unlabelled | 100 | ng/mL | CS4, BDE 183L | |
Decabromodiphenyl ether (13C12,99%) (BDE 209)
|
[1163-19-5]/unlabelled | 1000 | ng/mL | CS4, BDE 209L | |
2,2',3,4,4',6-Hexabromodiphenyl ether (13C12,99%) (BDE 139)
|
[446254-96-2]/unlabelled | 100 | ng/mL | CS4, Labeled Clean-up, BDE 139L | |
2,2',5,5'-Tetrachlorobiphenyl (13C12,99%) (IUPAC #52)
|
[208263-80-3] | 100 | ng/mL | CS4, Labeled Injection Internal, PCB-52L | |
2,2',3,4,4',5'-Hexachlorobiphenyl (13C12,99%) (IUPAC #138)
|
[208263-66-5] | 100 | ng/mL | CS4, Labeled Injection Internal, PCB-138L | |
2,4,4'-Tribromodiphenyl Ether
|
[41318-75-6] | 2500 | ng/mL | CS5, BDE 28 | |
2,2',4,4'-Tetrabromodiphenyl Ether
|
[5436-43-1] | 2500 | ng/mL | CS5, BDE 47 | |
2,2',4,4',5-Pentabromodiphenyl Ether
|
[60348-60-9] | 2500 | ng/mL | CS5, BDE 99 | |
2,2',4,4',6-Pentabromodiphenyl Ether
|
[189084-64-8] | 2500 | ng/mL | CS5, BDE 100 | |
2,2',4,4',5,5'-Hexabromodiphenyl Ether
|
[68631-49-2] | 2500 | ng/mL | CS5, BDE 153 | |
2,2',4,4',5,6'-Hexabromodiphenyl Ether
|
[207122-15-4] | 2500 | ng/mL | CS5, BDE 154 | |
2,2',3,4,4',5',6-Heptabromodiphenyl Ether
|
[207122-16-5] | 2500 | ng/mL | CS5, BDE 183 | |
Decabromodiphenyl ether (BDE 209)
|
[1163-19-5] | 25000 | ng/mL | CS5, BDE 209 | |
2,4,4'-Tribromodiphenyl ether (13C12,99%) (BDE 28)
|
[41318-75-6]/unlabelled | 100 | ng/mL | CS5, BDE 28L | |
2,2',4,4'-Tetrabromodiphenyl ether (13C12,99%) (BDE 47)
|
[5436-43-1]/unlabelled | 100 | ng/mL | CS5, BDE 47L | |
2,2',4,4',5-Pentabromodiphenyl ether (13C12,99%) (BDE 99)
|
[60348-60-9]/unlabelled | 100 | ng/mL | CS5, BDE 99L | |
2,2',4,4',6-Pentabromodiphenyl ether (13C12,99%) (BDE 100)
|
[189084-64-8]/unlabelled | 100 | ng/mL | CS5, BDE 100L | |
2,2',4,4',5,5'-Hexabromodiphenyl ether (13C12,99%) (BDE 153)
|
[68631-49-2]/unlabelled | 100 | ng/mL | CS5, BDE 153L | |
2,2',4,4',5,6'-Hexabromodiphenyl ether (13C12,99%) (BDE 154)
|
[488710-23-2] | 100 | ng/mL | CS5, BDE 154L | |
2,2',3,4,4',5',6-Heptabromodiphenyl ether (13C12,99%) (BDE 183)
|
[207122-16-5]/unlabelled | 100 | ng/mL | CS5, BDE 183L | |
Decabromodiphenyl ether (13C12,99%) (BDE 209)
|
[1163-19-5]/unlabelled | 1000 | ng/mL | CS5, BDE 209L | |
2,2',3,4,4',6-Hexabromodiphenyl ether (13C12,99%) (BDE 139)
|
[446254-96-2]/unlabelled | 100 | ng/mL | CS5, Labeled Clean-up, BDE 139L | |
2,2',5,5'-Tetrachlorobiphenyl (13C12,99%) (IUPAC #52)
|
[208263-80-3] | 100 | ng/mL | CS5, Labeled Injection Internal, PCB-52L | |
2,2',3,4,4',5'-Hexachlorobiphenyl (13C12,99%) (IUPAC #138)
|
[208263-66-5] | 100 | ng/mL | CS5, Labeled Injection Internal, PCB-138L |
Miscellaneous
Certificate of Analysis (specimen)
Reference Material CoA specimen: for the current lot, please contact your customer service representative at info@labmix24.com
Product data sheet
View all available product details e.g. description, analytes/parameters, CAS Number, concentrations/values, sales unit/product format, method, source, transport information
With more than 40 years of experience, Cambridge Isotope Laboratories are the world leader in the separation and manufacture of stable isotopes and stable isotope labeled compounds.
CIL specializes in labelling biochemical and organic compounds with highly enriched, stable (non-radioactive) isotopes of carbon, hydrogen, nitrogen and oxygen (e.g., 2H or D, 13C, 15N, 18O), so that the final product can be readily measured or traced using mass spectrometry (mass spec) or nuclear magnetic resonance (NMR).
We supply an extensive portfolio of CIL’s reference standards to support testing applications such as food and feed testing for contaminants, impurities and adulterants; materials testing to ensure compliance with standards; environmental testing for traces of pharmaceuticals and personal care products, soil and sediment testing, water testing (groundwater, wastewater, and drinking water), and pesticide testing.